News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,000 Results
Type
Article (88729)
Company Profile (816)
Press Release (793432)
Multimedia
Podcasts (235)
Webinars (35)
Section
Business (233568)
Career Advice (4161)
Deals (39978)
Drug Delivery (176)
Drug Development (91683)
Employer Resources (207)
FDA (18546)
Job Trends (17482)
News (398681)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3051)
Academic (2)
Accelerated approval (55)
Adcomms (40)
Allergies (191)
Alliances (56988)
ALS (232)
Alzheimer's disease (1960)
Antibody-drug conjugate (ADC) (541)
Approvals (18872)
Artificial intelligence (851)
Autoimmune disease (345)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6490)
Cardiovascular disease (547)
Career advice (3595)
Career pathing (51)
CAR-T (378)
CDC (76)
Celiac Disease (3)
Cell therapy (1054)
Cervical cancer (53)
Clinical research (78850)
Collaboration (2330)
Company closure (8)
Compensation (1485)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1259)
Cystic fibrosis (166)
Data (8530)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (95)
Diabetes (659)
Diagnostics (7574)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (415)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102469)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138381)
Executive appointments (1183)
FDA (22557)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1910)
Gene editing (269)
Generative AI (87)
Gene therapy (844)
GLP-1 (1261)
Government (5555)
Grass and pollen (8)
Guidances (418)
Healthcare (21236)
HIV (91)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (110)
Immunology and inflammation (351)
Immuno-oncology (113)
Indications (201)
Infectious disease (3431)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (312)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5207)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (118)
Layoffs (684)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (864)
Lymphoma (455)
Machine learning (65)
Management (66)
Manufacturing (1195)
MASH (221)
Medical device (15258)
Medtech (15402)
Mergers & acquisitions (23258)
Metabolic disorders (1756)
mRNA (263)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (498)
Neuropsychiatric disorders (126)
Neuroscience (3676)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5140)
Now hiring (80)
Obesity (844)
Opinion (371)
Ovarian cancer (242)
Pain (281)
Pancreatic cancer (341)
Parkinson's disease (409)
Partnered (39)
Patents (644)
Patient recruitment (732)
Peanut (69)
People (67912)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24371)
Phase 2 (34254)
Phase 3 (25754)
Pipeline (9520)
Policy (395)
Postmarket research (3559)
Preclinical (10955)
Press Release (72)
Prostate cancer (341)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1234)
Real estate (7462)
Recruiting (81)
Regulatory (30297)
Reports (77)
Research institute (2768)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (231)
Service/supplier (28)
Sickle cell disease (125)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (143)
Vaccines (1299)
Venture capital (130)
Weight loss (578)
Women's health (137)
Worklife (24)
Date
Today (140)
Last 7 days (801)
Last 30 days (3650)
Last 365 days (33108)
2026 (15360)
2025 (33221)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52231)
Australia (9184)
California (14213)
Canada (3974)
China (1536)
Colorado (610)
Connecticut (633)
Delaware (438)
Europe (120434)
Florida (2102)
Georgia (464)
Hawaii (4)
Idaho (70)
Illinois (1228)
India (101)
Indiana (659)
Iowa (25)
Japan (580)
Kansas (143)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1728)
Massachusetts (10387)
Michigan (421)
Minnesota (791)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3765)
New Mexico (34)
New York (3735)
North Carolina (1920)
North Dakota (11)
Northern California (7054)
Ohio (442)
Oklahoma (26)
Oregon (55)
Pennsylvania (2813)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5571)
Tennessee (224)
Texas (2308)
United States (50852)
Utah (425)
Vermont (1)
Virginia (360)
Washington D.C. (89)
Washington State (1169)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,000 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
ASCO’s biggest winners showcased a new era of cancer innovation
Revolution Medicines stole the show at the 2026 American Society of Clinical Oncology meeting as full data from its pancreatic cancer drug lived up to expectations, while Summit and Akeso proved the PD-(L)1/VEGF mechanism and Eli Lilly showed that its in vivo CAR T bet is paying off.
June 3, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
June 3, 2026
·
9 min read
Press Releases
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
June 3, 2026
·
9 min read
Press Releases
Konica Minolta Healthcare Expands Service Offerings and Updates AeroRemote Insights with In-Depth Analytics and Operational Intelligence to Help Facilities Address Current Department Challenges
June 3, 2026
·
4 min read
Press Releases
Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
June 3, 2026
·
5 min read
Press Releases
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
June 3, 2026
·
7 min read
Press Releases
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
June 3, 2026
·
3 min read
Press Releases
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
June 3, 2026
·
4 min read
Press Releases
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
June 3, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
1 of 88,300
Next
